Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2011

01-02-2011 | Case Report

Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure

Authors: Ryoko Horikoshi, Tetsu Akimoto, Daishi Meguro, Osamu Saito, Yasuhiro Ando, Shigeaki Muto, Eiji Kusano

Published in: Clinical and Experimental Nephrology | Issue 1/2011

Login to get access

Abstract

A 56-year-old male with chronic renal failure was admitted to the hospital because of progressive hip pain, appetite loss, general fatigue, and hypercalcemia. Slight pain had developed in the left hip 3 months before the initiation of hemodialysis, which subsequently developed into hyperalgesia. The patient was suspected to have sarcoidosis based on the elevated serum angiotensin-converting enzyme and lysozyme levels, and the ocular finding characterized by punched out chorioretinal scarring, although this could not be confirmed by histological evaluations. There was an abnormal uptake of gallium in the dependent portion of the tumoral calcinosis, which could have suggested either the presence of granulomatous sarcoid tissue within the calcified mass or active calcification associated with an inflammatory reaction. Elevated serum concentrations of 1,25-dihydroxyvitamin D3, which should be implicated in the development of hypercalcemia, promptly decreased after the administration of steroids. Steroid administration subsequently led to a decrease in the serum calcium and relief of the hip pain. This was a rare case of sarcoidosis associated with symptomatic tumoral calcinosis and hypercalcemia. The diagnostic significance of a gallium scan in this case will also be discussed.
Literature
1.
go back to reference Pecovnik-Balon B, Kramberger S. Tumoral calcinosis in patients on hemodialysis. Am J Nephrol. 1997;17:93–5.CrossRefPubMed Pecovnik-Balon B, Kramberger S. Tumoral calcinosis in patients on hemodialysis. Am J Nephrol. 1997;17:93–5.CrossRefPubMed
2.
go back to reference Phanish MK, Kallarackal G, Ravanan R, Lawson TM, Baboolal K. Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a hemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant. 2000;15:1691–3.CrossRefPubMed Phanish MK, Kallarackal G, Ravanan R, Lawson TM, Baboolal K. Tumoral calcinosis associated with pyrexia and systemic inflammatory response in a hemodialysis patient: successful treatment using intravenous pamidronate. Nephrol Dial Transplant. 2000;15:1691–3.CrossRefPubMed
3.
go back to reference Eisenberg B, Tzamaloukas AH, Hartshorne MF, Listrom MB, Arrington ER, Sherrard DJ. Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report. J Nucl Med. 1990;31:1099–103.PubMed Eisenberg B, Tzamaloukas AH, Hartshorne MF, Listrom MB, Arrington ER, Sherrard DJ. Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report. J Nucl Med. 1990;31:1099–103.PubMed
4.
go back to reference Naito T, Nitta K, Kamita N, Honda K, Yoshida T, Koinuma M, et al. Progressive tumoral calcinosis as the presenting feature of sarcoidosis in a patient on hemodialysis treatment. Nephrol Dial Transplant. 1999;14:2716–9.CrossRefPubMed Naito T, Nitta K, Kamita N, Honda K, Yoshida T, Koinuma M, et al. Progressive tumoral calcinosis as the presenting feature of sarcoidosis in a patient on hemodialysis treatment. Nephrol Dial Transplant. 1999;14:2716–9.CrossRefPubMed
5.
go back to reference Hodnett P, Moore M, Kinsella S, Kelly D, Plant WD, Maher MM. Radiological features of progressive tumoral calcinosis in chronic renal failure. Australas Radiol. 2007;51:B115–8.CrossRefPubMed Hodnett P, Moore M, Kinsella S, Kelly D, Plant WD, Maher MM. Radiological features of progressive tumoral calcinosis in chronic renal failure. Australas Radiol. 2007;51:B115–8.CrossRefPubMed
6.
go back to reference Rima A, Cardinal E, Bureau NJ, Aubin B, Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology. 2001;221:455–61.CrossRef Rima A, Cardinal E, Bureau NJ, Aubin B, Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology. 2001;221:455–61.CrossRef
7.
go back to reference Hammert WC, Lindsay LR. Tumoral calcinosis-or is it? A case report and review. Hand. 2009;4:119–22.CrossRefPubMed Hammert WC, Lindsay LR. Tumoral calcinosis-or is it? A case report and review. Hand. 2009;4:119–22.CrossRefPubMed
8.
go back to reference Rothova A. Ocular involvement in sarcoidosis. Br J Opthalmol. 2000;84:110–6.CrossRef Rothova A. Ocular involvement in sarcoidosis. Br J Opthalmol. 2000;84:110–6.CrossRef
9.
go back to reference Johnson DG, Johnson SM, Harris CC, Piantadosi CA, Blinder RA, Coleman RE. Ga-67 uptake in the lung sarcoidosis. Radiology. 1984;150:551–5.PubMed Johnson DG, Johnson SM, Harris CC, Piantadosi CA, Blinder RA, Coleman RE. Ga-67 uptake in the lung sarcoidosis. Radiology. 1984;150:551–5.PubMed
10.
go back to reference Soudry G, Connoly LP, Treves ST. Ga-67 imaging of tumoral calcinosis associated with secondary hyperparathyroidism. Clin Nucl Med. 1996;21:68–9.CrossRefPubMed Soudry G, Connoly LP, Treves ST. Ga-67 imaging of tumoral calcinosis associated with secondary hyperparathyroidism. Clin Nucl Med. 1996;21:68–9.CrossRefPubMed
11.
go back to reference Israel HL, Goldstein RA. Frequency of disordered calcium metabolism in sarcoidosis. Postgrad Med J. 1970;46:468–70.CrossRefPubMed Israel HL, Goldstein RA. Frequency of disordered calcium metabolism in sarcoidosis. Postgrad Med J. 1970;46:468–70.CrossRefPubMed
12.
go back to reference Conron M, Young C, Beynon C. Review calcium metabolism in sarcoidosis and its clinical implications. Rheumatology. 2000;39:707–13.CrossRefPubMed Conron M, Young C, Beynon C. Review calcium metabolism in sarcoidosis and its clinical implications. Rheumatology. 2000;39:707–13.CrossRefPubMed
13.
go back to reference Monkawa T, Yoshida T, Hayashi M, Saruta T. Identification of 25-hydroxyvitamin D3 1a-hydroxylase gene expression in macrophages. Kidney Int. 2000;58:559–68.CrossRefPubMed Monkawa T, Yoshida T, Hayashi M, Saruta T. Identification of 25-hydroxyvitamin D3 1a-hydroxylase gene expression in macrophages. Kidney Int. 2000;58:559–68.CrossRefPubMed
14.
go back to reference Kalantar Zedeh K, Nuemayer HH, Wunsch PH, Luft FC. Hypercalcemia and sarcoidosis in an anephric dialysis patient. Nephrol Dial Transplant. 1994;9:829–31. Kalantar Zedeh K, Nuemayer HH, Wunsch PH, Luft FC. Hypercalcemia and sarcoidosis in an anephric dialysis patient. Nephrol Dial Transplant. 1994;9:829–31.
15.
go back to reference Brandi L, Daugaard H, Tvedegaard E. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Nephron. 1989;53:194–200.CrossRefPubMed Brandi L, Daugaard H, Tvedegaard E. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis. Nephron. 1989;53:194–200.CrossRefPubMed
16.
go back to reference Baker LRI, Abrams SML, Roe CJ, Faugere MC, Fanti P, Subayti Y, et al. 1, 25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989;35:661–9.CrossRefPubMed Baker LRI, Abrams SML, Roe CJ, Faugere MC, Fanti P, Subayti Y, et al. 1, 25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int. 1989;35:661–9.CrossRefPubMed
17.
go back to reference Gallieni M, Kamimura S, Ahmed A, Bravo E, Delmez J, Slatopolsky E, et al. Kinetics of monocyte 1α-hydroxylase in renal failure. Am J Physiol. 1995;268:F746–53.PubMed Gallieni M, Kamimura S, Ahmed A, Bravo E, Delmez J, Slatopolsky E, et al. Kinetics of monocyte 1α-hydroxylase in renal failure. Am J Physiol. 1995;268:F746–53.PubMed
18.
go back to reference Putkonen T, Hannuksela M, Halme H. Calcium and phosphorus metabolism in sarcoidosis. Acta Med Scand. 1965;177:327–35.PubMed Putkonen T, Hannuksela M, Halme H. Calcium and phosphorus metabolism in sarcoidosis. Acta Med Scand. 1965;177:327–35.PubMed
20.
go back to reference Motoyama K, Inaba M, Emoto M, Morii H, Nishizawa Y. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Intern Med. 2002;41:449–52.CrossRefPubMed Motoyama K, Inaba M, Emoto M, Morii H, Nishizawa Y. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Intern Med. 2002;41:449–52.CrossRefPubMed
21.
go back to reference Crystal RG. Sarcoidosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principle of internal medicine 13th edn. New York: McGraw-Hill; 1994. p. 1679–84. Crystal RG. Sarcoidosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison’s principle of internal medicine 13th edn. New York: McGraw-Hill; 1994. p. 1679–84.
22.
go back to reference Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 2006;26:871–85.CrossRefPubMed Olsen KM, Chew FS. Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics. 2006;26:871–85.CrossRefPubMed
23.
go back to reference Akimoto T, Saito O, Kotoda A, Nishino K, Umino T, Muto S, et al. A case of recurrent renal failure associated with metabolic alkalosis induced by protracted vomiting. Clin Exp Nephrol. 2006;10:279–83.CrossRefPubMed Akimoto T, Saito O, Kotoda A, Nishino K, Umino T, Muto S, et al. A case of recurrent renal failure associated with metabolic alkalosis induced by protracted vomiting. Clin Exp Nephrol. 2006;10:279–83.CrossRefPubMed
24.
go back to reference Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol. 1995;43:531–6.CrossRef Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol. 1995;43:531–6.CrossRef
25.
go back to reference Fogelman I, Mckillop JH, Cowden EA, Fine A, Boyce B, Boyle IT, et al. Bone scan findings in hypervitaminosis D: case report. J Nucl Med. 1977;18:1205–7.PubMed Fogelman I, Mckillop JH, Cowden EA, Fine A, Boyce B, Boyle IT, et al. Bone scan findings in hypervitaminosis D: case report. J Nucl Med. 1977;18:1205–7.PubMed
26.
go back to reference Ahmed M, Almahfouz A, Alarifi A, Nasser T, Alkahtani N, Dayel FA. Hyperparathyroidism secondary to vitamin D deficiency. Clin Nucl Med. 2003;28:413–5.CrossRefPubMed Ahmed M, Almahfouz A, Alarifi A, Nasser T, Alkahtani N, Dayel FA. Hyperparathyroidism secondary to vitamin D deficiency. Clin Nucl Med. 2003;28:413–5.CrossRefPubMed
27.
go back to reference Lambrinoudaki L, Christodoulakos G, Botsis D. Bisphosphonate. Ann N Y Acad Sci. 2006;1092:397–402.CrossRefPubMed Lambrinoudaki L, Christodoulakos G, Botsis D. Bisphosphonate. Ann N Y Acad Sci. 2006;1092:397–402.CrossRefPubMed
28.
go back to reference Gibbs CJ, Peacock M. Hypercalcemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J. 1986;62:937–8.CrossRefPubMed Gibbs CJ, Peacock M. Hypercalcemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J. 1986;62:937–8.CrossRefPubMed
29.
go back to reference Wenzel C, Bartsch R, Hussian D, Pluschnig U, Locker GJ, Sevelda U, et al. Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Support Care Cancer. 2004;12:678–81.PubMed Wenzel C, Bartsch R, Hussian D, Pluschnig U, Locker GJ, Sevelda U, et al. Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Support Care Cancer. 2004;12:678–81.PubMed
30.
go back to reference Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, et al. American society of clinical oncology 2007 Clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007;25:2464–72.CrossRefPubMed Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, et al. American society of clinical oncology 2007 Clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007;25:2464–72.CrossRefPubMed
Metadata
Title
Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure
Authors
Ryoko Horikoshi
Tetsu Akimoto
Daishi Meguro
Osamu Saito
Yasuhiro Ando
Shigeaki Muto
Eiji Kusano
Publication date
01-02-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0362-4

Other articles of this Issue 1/2011

Clinical and Experimental Nephrology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.